| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Suzanne H Gage, Stanley Zammit, Matthew Hickma. Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. F1000 medicine reports. vol 5. 2013-01-31. PMID:23361397. |
we believe that, while such uncertainty exists, there is a scientific duty to continue to investigate the role of cannabis in the aetiology of schizophrenia and that the policy case for considering cannabis exposure as a critical target for preventing schizophrenia is yet to be made. |
2013-01-31 |
2023-08-12 |
Not clear |
| Krzysztof Krysta, Irena Krupka-Matuszczyk, Małgorzata Janas-Kozik, Małgorzata Stachowicz, Jan Szymszal, Janusz K Rybakowsk. Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis. Medical science monitor : international medical journal of experimental and clinical research. vol 18. issue 9. 2013-01-08. PMID:22936195. |
inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis. |
2013-01-08 |
2023-08-12 |
Not clear |
| Verity C Leeson, Isobel Harrison, Maria A Ron, Thomas R E Barnes, Eileen M Joyc. The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophrenia bulletin. vol 38. issue 4. 2012-12-27. PMID:21389110. |
the effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. |
2012-12-27 |
2023-08-12 |
Not clear |
| Verity C Leeson, Isobel Harrison, Maria A Ron, Thomas R E Barnes, Eileen M Joyc. The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophrenia bulletin. vol 38. issue 4. 2012-12-27. PMID:21389110. |
we aimed to clarify the role of age at onset and cognition on outcomes in cannabis users with first-episode schizophrenia as well as the effect of cannabis dose and cessation of use. |
2012-12-27 |
2023-08-12 |
Not clear |
| M Smeerdijk, R Keet, N Dekker, B van Raaij, M Krikke, M Koeter, L de Haan, C Barrowclough, G Schippers, D Linsze. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial. Psychological medicine. vol 42. issue 8. 2012-12-19. PMID:22152121. |
motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial. |
2012-12-19 |
2023-08-12 |
Not clear |
| M Smeerdijk, R Keet, N Dekker, B van Raaij, M Krikke, M Koeter, L de Haan, C Barrowclough, G Schippers, D Linsze. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial. Psychological medicine. vol 42. issue 8. 2012-12-19. PMID:22152121. |
cannabis use by people with schizophrenia has been found to be associated with family distress and poor clinical outcomes. |
2012-12-19 |
2023-08-12 |
Not clear |
| Patrik Roser, Silke Lissek, Martin Tegenthoff, Volkmar Nicolas, Georg Juckel, Martin Brün. Alterations of theory of mind network activation in chronic cannabis users. Schizophrenia research. vol 139. issue 1-3. 2012-12-07. PMID:22695256. |
chronic cannabis use is associated with cognitive impairment and has been identified as a risk factor for schizophrenia. |
2012-12-07 |
2023-08-12 |
human |
| Juan A Galvez-Buccollini, Ashley C Proal, Veronica Tomaselli, Melissa Trachtenberg, Cristinel Coconcea, Jinsoo Chun, Theo Manschreck, Jerry Fleming, Lynn E Delis. Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis. Schizophrenia research. vol 139. issue 1-3. 2012-12-07. PMID:22727454. |
several studies have associated cannabis use with the development of schizophrenia. |
2012-12-07 |
2023-08-12 |
Not clear |
| Maju Mathew Koola, Robert P McMahon, Heidi J Wehring, Fang Liu, Kristen M Mackowick, Kimberly R Warren, Stephanie Feldman, Joo-Cheol Shim, Raymond C Love, Deanna L Kell. Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders. Journal of psychiatric research. vol 46. issue 8. 2012-12-04. PMID:22595870. |
alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders. |
2012-12-04 |
2023-08-12 |
human |
| S Lev-Ran, A Segev, Y Braw, Y Levkovit. Neurocognitive functions of heavy cannabis using schizophrenia patients. European psychiatry : the journal of the Association of European Psychiatrists. vol 27. issue 5. 2012-11-06. PMID:21704501. |
neurocognitive functions of heavy cannabis using schizophrenia patients. |
2012-11-06 |
2023-08-12 |
human |
| S Lev-Ran, A Segev, Y Braw, Y Levkovit. Neurocognitive functions of heavy cannabis using schizophrenia patients. European psychiatry : the journal of the Association of European Psychiatrists. vol 27. issue 5. 2012-11-06. PMID:21704501. |
this current study assessed neurocognitive functioning in a carefully selected sample of schizophrenia patients with and without heavy cannabis use and healthy controls. |
2012-11-06 |
2023-08-12 |
human |
| S Lev-Ran, A Segev, Y Braw, Y Levkovit. Neurocognitive functions of heavy cannabis using schizophrenia patients. European psychiatry : the journal of the Association of European Psychiatrists. vol 27. issue 5. 2012-11-06. PMID:21704501. |
cannabis using schizophrenia patients had focused impairments on tasks of attention, and the findings suggest an impulsive pattern of response among these patients. |
2012-11-06 |
2023-08-12 |
human |
| Else-Marie Løberg, Merethe Nygård, Jan Øystein Berle, Erik Johnsen, Rune A Kroken, Hugo A Jørgensen, Kenneth Hugdah. An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use. Frontiers in psychiatry. vol 3. 2012-11-02. PMID:23115554. |
an fmri study of neuronal activation in schizophrenia patients with and without previous cannabis use. |
2012-11-02 |
2023-08-12 |
Not clear |
| Else-Marie Løberg, Merethe Nygård, Jan Øystein Berle, Erik Johnsen, Rune A Kroken, Hugo A Jørgensen, Kenneth Hugdah. An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use. Frontiers in psychiatry. vol 3. 2012-11-02. PMID:23115554. |
twenty-six patients with a dsm-iv and icd-10 diagnosis of schizophrenia were grouped into a previous cannabis user group and a no-cannabis group. |
2012-11-02 |
2023-08-12 |
Not clear |
| Else-Marie Løberg, Merethe Nygård, Jan Øystein Berle, Erik Johnsen, Rune A Kroken, Hugo A Jørgensen, Kenneth Hugdah. An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use. Frontiers in psychiatry. vol 3. 2012-11-02. PMID:23115554. |
it is concluded that the present study show some differences in brain activation to a cognitively challenging task between previous cannabis and no-cannabis schizophrenia patients. |
2012-11-02 |
2023-08-12 |
Not clear |
| Thomas Schnell, Alexandra Kleiman, Euphrosyne Gouzoulis-Mayfrank, Jörg Daumann, Benjamin Becke. Increased gray matter density in patients with schizophrenia and cannabis use: a voxel-based morphometric study using DARTEL. Schizophrenia research. vol 138. issue 2-3. 2012-10-24. PMID:22475382. |
increased gray matter density in patients with schizophrenia and cannabis use: a voxel-based morphometric study using dartel. |
2012-10-24 |
2023-08-12 |
Not clear |
| Thomas Schnell, Alexandra Kleiman, Euphrosyne Gouzoulis-Mayfrank, Jörg Daumann, Benjamin Becke. Increased gray matter density in patients with schizophrenia and cannabis use: a voxel-based morphometric study using DARTEL. Schizophrenia research. vol 138. issue 2-3. 2012-10-24. PMID:22475382. |
the counterintuitive finding of better cognitive performance in patients with schizophrenia and cannabis use (sch+can patients) compared to cannabis naïve patients is discussed as a reflection of lower vulnerability for schizophrenia in at least one subgroup of sch+can patients. |
2012-10-24 |
2023-08-12 |
Not clear |
| Adriana Caballero, Kuei Y Tsen. Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia. Frontiers in pharmacology. vol 3. 2012-10-02. PMID:22654759. |
association of cannabis use during adolescence, prefrontal cb1 receptor signaling, and schizophrenia. |
2012-10-02 |
2023-08-12 |
human |
| Aine T Behan, Magdalena Hryniewiecka, Colm M P O'Tuathaigh, Anthony Kinsella, Mary Cannon, Maria Karayiorgou, Joseph A Gogos, John L Waddington, David R Cotte. Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 37. issue 7. 2012-09-21. PMID:22434221. |
a high-low activity polymorphism in catechol-o-methyltransferase (comt), a gene encoding the comt enzyme involved in dopamine clearance in the brain, may interact with adolescent cannabis exposure to increase risk for schizophrenia. |
2012-09-21 |
2023-08-12 |
mouse |
| Aine T Behan, Magdalena Hryniewiecka, Colm M P O'Tuathaigh, Anthony Kinsella, Mary Cannon, Maria Karayiorgou, Joseph A Gogos, John L Waddington, David R Cotte. Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 37. issue 7. 2012-09-21. PMID:22434221. |
these findings illuminate how comt deletion and adolescent cannabis use can interact to modulate the function of neurotransmitters systems implicated in schizophrenia. |
2012-09-21 |
2023-08-12 |
mouse |